Clinical Cancer Research, Vol 4, Issue 2 517-524, Copyright © 1998 by American Association for Cancer Research

ARTICLES

bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues

M Marone, G Scambia, S Mozzetti, G Ferrandina, S Iacovella, A De Pasqua, P Benedetti-Panici and S Mancuso
Department of Obstetrics and Gynecology, Catholic University, Rome, Italy.

The bcl-2 family of proteins includes some important regulators of apoptosis. Among these, bcl-2 and bcl-xL prevent cells from entering apoptosis, whereas bax and bcl-xS can induce cell death. Alterations in the control of this process can lead to a decrease in cell death, thus contributing to neoplastic growth. Diminished susceptibility to chemotherapy has also been attributed, in in vitro systems, to alterations in the levels of bcl-2, bax, or bcl-x. We analyzed the expression of bcl-2, bax, bcl-xL, and bcl-xS in normal and neoplastic ovarian tissues by reverse transcriptase-PCR and Western blotting. The RNA and protein levels were significantly correlated for all genes. Interestingly, the levels of these genes in normal and neoplastic tissues were significantly different: bcl-2 was higher in normal tissue (P < 0.002), whereas bax and bcl-xL were higher in carcinoma (P < 0.018 and P < 0.030, respectively). bcl-xS was present at low levels in 83% of neoplastic samples and was undetectable in normal tissue. Reverse transcriptase-PCR analysis of 74 tumors showed no major correlation with clinicopathological parameters or with response to chemotherapy. Only bax and bcl-xL were correlated with progesterone receptor levels (n = 29, r = +0.44, P < 0.0189, and r = -0.40, P < 0.035, respectively). No correlation was found with estrogen receptor levels or with p53 immunostaining. Our data indicate that the regulation of the bcl-2 family of proteins differs between normal and neoplastic ovarian tissues. Moreover, the modulation of these genes in ovarian carcinoma is different compared to other tissues; therefore, tissue specificity is very important in regulation of the bcl-2 family of proteins.

This article has been cited by other articles:

				C. M. Annunziata, L. Kleinberg, B. Davidson, A. Berner, D. Gius, N. Tchabo, S. M. Steinberg, and E. C. Kohn BAG-4/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6585 - 6592. [Abstract] [Full Text] [PDF]

				M. R. Hussein Apoptosis in the ovary: molecular mechanisms Hum. Reprod. Update, March 1, 2005; 11(2): 162 - 178. [Abstract] [Full Text] [PDF]

				S. Camilleri-Broet, A. C. Hardy-Bessard, A. Le Tourneau, D. Paraiso, O. Levrel, B. Leduc, S. Bain, H. Orfeuvre, J. Audouin, and E. Pujade-Lauraine HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group Ann. Onc., January 1, 2004; 15(1): 104 - 112. [Abstract] [Full Text] [PDF]

				C. Ferlini, G. Raspaglio, S. Mozzetti, M. Distefano, F. Filippetti, E. Martinelli, G. Ferrandina, D. Gallo, F. O. Ranelletti, and G. Scambia Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance Mol. Pharmacol., July 1, 2003; 64(1): 51 - 58. [Abstract] [Full Text] [PDF]

				G. Riedlinger, R. Okagaki, K.-U. Wagner, E. B. Rucker III, T. Oka, K. Miyoshi, J. A. Flaws, and L. Hennighausen Bcl-x Is Not Required for Maintenance of Follicles and Corpus Luteum in the Postnatal Mouse Ovary Biol Reprod, February 1, 2002; 66(2): 438 - 444. [Abstract] [Full Text] [PDF]

				A. Frankel, K. Rosen, J. Filmus, and R. S. Kerbel Induction of Anoikis and Suppression of Human Ovarian Tumor Growth in Vivo by Down-Regulation of Bcl-XL Cancer Res., June 1, 2001; 61(12): 4837 - 4841. [Abstract] [Full Text] [PDF]

				M. Baekelandt, R. Holm, J. M. Nesland, C. G. Trope, and G. B. Kristensen Expression of Apoptosis-Related Proteins Is an Independent Determinant of Patient Prognosis in Advanced Ovarian Cancer J. Clin. Oncol., November 15, 2000; 18(22): 3775 - 3781. [Abstract] [Full Text] [PDF]

				C. D. Hough, C. A. Sherman-Baust, E. S. Pizer, F. J. Montz, D. D. Im, N. B. Rosenshein, K. R. Cho, G. J. Riggins, and P. J. Morin Large-Scale Serial Analysis of Gene Expression Reveals Genes Differentially Expressed in Ovarian Cancer Cancer Res., November 1, 2000; 60(22): 6281 - 6287. [Abstract] [Full Text]

				L. Pierelli, M. Marone, G. Bonanno, S. Mozzetti, S. Rutella, R. Morosetti, C. Rumi, S. Mancuso, G. Leone, and G. Scambia Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta 1 is a cell cycle-independent effect and influences their hematopoietic potential Blood, May 15, 2000; 95(10): 3001 - 3009. [Abstract] [Full Text] [PDF]

				M. Baekelandt, G. B. Kristensen, J. M. Nesland, C. G. Trope, and R. Holm Clinical Significance of Apoptosis-Related Factors p53, Mdm2, and Bcl-2 in Advanced Ovarian Cancer J. Clin. Oncol., July 1, 1999; 17(7): 2061 - 2061. [Abstract] [Full Text] [PDF]